The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Glenmark launches antidiabetic drug in India
The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 3, 2024 Category: Pharmaceuticals Source Type: news

BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form
It is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The company said introducing the Drug Controller General of India (DCGI)approved new drug delivery system will make it more affordable and accessible in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2024 Category: Pharmaceuticals Source Type: news

Investments worth Rs 25,813 crore made under pharma PLI as of Sept 2023: Govt
The government has announced that investments totalling Rs 25,813 crore have been infused into the pharmaceutical sector, leading to the addition of 56,171 new jobs under the production-linked incentive scheme till September this year. In its year-end review, the Department of Pharmaceuticals (DoP) also highlighted the successful accomplishment of the 'Pradhan Mantri Bhartiya Janaushadhi Pariyojana,' meeting its goal of establishing 10,000 retail outlets in 2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 29, 2023 Category: Pharmaceuticals Source Type: news

Benzodiazepine use linked with increased miscarriage risk, says new study
Pregnancies resulting in miscarriage between 2004 and 2018 were included in the case group and matched in a 1:1 ratio with control individuals. The study, published in the journal JAMA Psychiatry, included 3,067,122 (over 30 lakh) pregnancies among 1,957,601 (over 19 lakh) women. It was found that 4.4 per cent of these pregnancies resulted in miscarriage. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 29, 2023 Category: Pharmaceuticals Source Type: news

India's pharma lobby bats for drug approvals in line with global markets
According to the OPPI, launching a new drug in India is delayed by up to four years, compared to markets like the US and the European Union. This affects the launch of innovative and significant products in India. The lobby represents pharma giants including Novartis, Roche, AstraZeneca, Sanofi and Merck. The group blames the delay on complex clinical trial regulations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2023 Category: Pharmaceuticals Source Type: news

IIL begins construction of Rs 700 crore facility to make FMD vaccines
The brand-new unit will have a BSL3 facility for the manufacture of drug substances and a fill-finish capability for the production of both drug products FMD vaccine and the FMD+HS vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 28, 2023 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for generic antifungal injection
The approval by the US Food & Drug Administration (USFDA) is for Posaconazole injection of 300 mg/16.7 mL (18 mg/mL), single-dose vial, Aurobindo Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 27, 2023 Category: Pharmaceuticals Source Type: news

Do you really need that antibiotic?
Swallowing an antibiotic is like carpet-bombing the trillions of microorganisms that live in the gut, killing not just the bad but the good, too, said Dr. Martin Blaser, author of the book "Missing Microbes" and director of the Center for Advanced Biotechnology and Medicine at Rutgers University. Drug-resistant bacteria are already in all of us; beneficial bacteria help keep them controlled. When an antibiotic wipes out beneficial bacteria, the resistant bugs can flourish, making present and future infections harder to treat (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 25, 2023 Category: Pharmaceuticals Source Type: news

Union Minister Sarbananda Sonowal assures Rs 200 cr investment for CSIR-NEIST in Jorhat to boost medicinal plant market of northeast India
The Minister assured complete support for an approximate investment of Rs 200 crores to build capacity around the medicinal plant sector of the region. This amount is aimed at creating infrastructure that will strengthen the medicinal plant storage for commercial purpose, boosting research and development of the local herbs and plants for medicinal purpose as well as providing a platform for traditional healers to further their treatments to a wider section of the society. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 24, 2023 Category: Pharmaceuticals Source Type: news

Maiden Pharma denies tampering with tests in probe of cough syrup deaths
Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana's Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 23, 2023 Category: Pharmaceuticals Source Type: news

Intas in pact with Spanish drug maker mAbxience to sell biosimilar etanercept in over 150 countries
mAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible for the development, manufacturing, and supply of the Etanercept biosimilar. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news

Zydus Lifesciences gets 6 observations from USFDA for API plant
The US Food and Drug Administration (USFDA) conducted the inspection from December 14 to December 22, 2023. The inspection closed with six observations, Zydus Lifesciences said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news

Biocon Biologics grants Sandoz exclusive rights to market biosimilar adalimumab in Japan
Adalimumab BS for subcutaneous injection is indicated for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news

Lupin to acquire established products in Europe, Canada from Sanofi for Rs 91 cr
Lupin has acquired a portfolio of established products in Europe and Canada from Sanofi for a purchase consideration of EUR 10 million. The deal, signed by Lupin Atlantis Holdings SA, Switzerland, will include brands AARANE in Germany and NALCROM in Canada and the Netherlands. The acquisition is of strategic interest, bringing accretive assets in the respiratory field to help structure the company's new respiratory franchise in Germany. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news

India probe into bribery claim in toxic syrup tests nears completion
India is close to finishing an investigation into a complaint that a state drug regulator helped switch samples of cough syrups linked to the deaths of children in Gambia before they were tested in India. The World Health Organization (WHO) linked the syrups made by India's Maiden Pharmaceuticals to the deaths of 70 children in the African country last year. India's government says tests at an Indian government laboratory showed the syrups were not toxic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 22, 2023 Category: Pharmaceuticals Source Type: news